Advertisement

Malignant Tumors of the Ampulla of Vater

  • W. Scheppach
  • H.-J. Gassel
  • J. G. Mueller

Abstract

About half the ampullary carcinomas cause jaundice early and are thus diagnosed at a resectable stage. Ampullectomy is acceptable for stage o-I tumors. Whipple’s operation is appropriate for patients with stage II, III and IV tumors showing pancreatic but not extrapancreatic infiltration. These patients should be devoid of any other significant comorbidity. Palliative endoscopic stenting of the bile duct alleviates symptoms associated with obstructive jaundice in patients with advanced cancer (stage IV/extrapancreatic infiltration, distant métastases) or inoperability. At present there is no indication for multimodal treatments (e.g., radiotherapy, chemotherapy, radio chemotherapy). The prognosis of ampullary carcinoma is better than that of pancreatic or cholangiocellular cancer. The single most important factor predicting survival is disease stage at the time of diagnosis.

Keywords

Bile Duct Pancreatic Duct Familial Adenomatous Polyposis Obstructive Jaundice Biliary Tract Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Benhamiche AM, Jouve JL, Manfredi S, Prost P, Isambert N, Faivre J (2000) Cancer of the ampulla of Vater: results of a 20-year population-based study. Eur J Gastroenterol Hepatol 12:75–79PubMedCrossRefGoogle Scholar
  2. 2.
    Chow WH, McLaughlin JK, Menck HR, Menck TM (1994) Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA). Cancer Causes Control 5:267–272PubMedCrossRefGoogle Scholar
  3. 3.
    Cannon ME, Carpenter SL, Elta GH et al. (1999) EUS compared with CT, magnetic resonance imaging, and angiography and the influence of biliary stenting on staging accuracy of ampullary neoplasms. Gastrointest Endosc 50:27–33PubMedCrossRefGoogle Scholar
  4. 4.
    Albores-Saavedra J, Henson DE, Klimstra DS (2000) Tumors of the Gallbladder, extrahepatic bile ducts, and ampulla of Vater. AFIP Atlas of Tumor Pathology, Third series, Fascicle 27Google Scholar
  5. 5.
    Takashima M, Ueki T, Nagai E, Yao T, Yamaguchi K, Tanaka M, Tsuneyoshi M (2000) Carcinoma of the Ampulla of Vater associated with or without adenoma: A clinico-pathologic analysis of 198 cases with reference to p53 and Ki67 immunohistochemical expressions. Mod Pathol 13:1300–1307PubMedCrossRefGoogle Scholar
  6. 6.
    Scarpa A, DiPace C, Talamini G et al. (2000) Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis. Gut 46:842–848PubMedCrossRefGoogle Scholar
  7. 7.
    Klinkenbijl JH, van der Schelling GP, Hop WC, van Pel R, Bruining HA, Jeekel J (1992) The advantages of pylorus-preserving pancreaticoduodenectomy in malignant disease of the pancreas and periampullary region. Ann Surg 216: 142–145PubMedCrossRefGoogle Scholar
  8. 8.
    Klein P, Reingruber B, Kastl S, Dworak O, Hohenberger W (1996) Is local excision of pT1-ampullary carcinomas justified? Eur J Surg Oncol 22: 366–371PubMedCrossRefGoogle Scholar
  9. 9.
    Park SW, Song SY, Chung JB, Lee SK, Moon YM, Kang JK, Park IS (2000) Endoscopic snare resection for tumors of the ampulla of Vater. Yonsei Med J 41:213–218PubMedGoogle Scholar
  10. 10.
    Kinkenbijl JH, Jeekel J, Sahmoud T et al. (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776–782CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • W. Scheppach
    • 1
  • H.-J. Gassel
    • 2
  • J. G. Mueller
    • 3
  1. 1.Bayerische Julius-Maximilians-Universität, Medizinische UniversitätsklinikWürzburgGermany
  2. 2.Bayerische Julius-Maximilians-Universität, Chirurgische UniversitätsklinikWürzburgGermany
  3. 3.Bayerische Julius-Maximilians-Universität, Pathologisches InstitutWürzburgGermany

Personalised recommendations